Brief: Abliva Receives Orphan Designation From European Commission For NV354

Abliva AB

14/12/2023 10:52

Dec 14 (Reuters) - Abliva AB  ABLI.ST :
    * RECEIVES ORPHAN DESIGNATION FROM THE EUROPEAN COMMISSION FOR ITS DRUG CANDIDATE NV354

Source text for Eikon:  ID:nMFN8SBkgZ 
Further company coverage:  ABLI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))